WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Jie Zhu
Partner
Corporate
Shanghai
jizhu@wsgr.com

D86-21-6165-1761

Download vCard
Open PDF
  • Extensive Transactional Experience

    Jie has represented corporations and private equity funds in a wide range of complex mergers, acquisitions, IPOs, joint ventures, spin-offs, and going-private transactions.

  • Represents Clients Across Industries

    Jie's clients include companies in the healthcare, technology, consumer products and services, telecommunications, entertainment, transportation, energy, finance, and real estate sectors.

Jie Zhu is a partner at Wilson Sonsini Goodrich & Rosati, where his practice is focused on mergers and acquisitions, private equity and capital markets transactions, and joint ventures.

Jie has represented corporations and private equity funds in a wide range of complex mergers, acquisitions, IPOs, joint ventures, spin-offs, and going-private transactions. He also has experience in advising on general corporate, partnership, securities law, anti-corruption law, and restructuring matters. Jie's transactional experience spans a variety of industries, including healthcare, technology, consumer products and services, telecommunications, entertainment, transportation, energy and natural resources, financial institutions and real estate.

Jie was formerly an associate with Milbank, Tweed, Hadley & McCloy in Hong Kong. He started his legal career at White & Case's New York office.

Jie is a native Mandarin speaker and fluent in English.

Experience

Jie Zhu is a partner at Wilson Sonsini Goodrich & Rosati, where his practice is focused on mergers and acquisitions, private equity and capital markets transactions, and joint ventures.

Jie has represented corporations and private equity funds in a wide range of complex mergers, acquisitions, IPOs, joint ventures, spin-offs, and going-private transactions. He also has experience in advising on general corporate, partnership, securities law, anti-corruption law, and restructuring matters. Jie's transactional experience spans a variety of industries, including healthcare, technology, consumer products and services, telecommunications, entertainment, transportation, energy and natural resources, financial institutions and real estate.

Jie was formerly an associate with Milbank, Tweed, Hadley & McCloy in Hong Kong. He started his legal career at White & Case's New York office.

Jie is a native Mandarin speaker and fluent in English.

Education
  • J.D., New York University School of Law, 2006
  • M.S., School of Computer Science, Carnegie Mellon University, 2001
  • M.S., Automation, Tsinghua University, 1999
  • B.E., Automation, Tsinghua University, 1998
Associations and Memberships
  • Member, American Bar Association
  • Member, New York State Bar Association
  • Co-founder and Director, Chinese Business Lawyers Association, a New York non-profit professional organization
Honors
  • Recognized as a notable practitioner in the 2023 edition of IFLR1000
Admissions
  • State Bar of New York
Credentials
Education
  • J.D., New York University School of Law, 2006
  • M.S., School of Computer Science, Carnegie Mellon University, 2001
  • M.S., Automation, Tsinghua University, 1999
  • B.E., Automation, Tsinghua University, 1998
Associations and Memberships
  • Member, American Bar Association
  • Member, New York State Bar Association
  • Co-founder and Director, Chinese Business Lawyers Association, a New York non-profit professional organization
Honors
  • Recognized as a notable practitioner in the 2023 edition of IFLR1000
Admissions
  • State Bar of New York

Select Representations

  • Warburg Pincus, Sequoia Capital, Boyu Capital, New Horizon Capital, L Capital, Carlyle, and LightSpeed Venture in various private equity investment and exit transactions
  • Tencent, DJI International, and Shanda in various financing and investment transactions
  • The buyer consortium and management team in the going-private transaction of WuXi PharmaTech
  • RDA Microelectronics in its sale to Tsinghua Unigroup
  • Integrated Silicon Solution Inc. in its sale to a consortium of Chinese buyers
  • Founder of Syswin Inc. in its going-private transaction
  • TJOY Holdings in its sale to Coty Inc.
  • State Grid International Development in its acquisition of electric power transmission assets in Brazil
  • ArtGo Mining and PW Medtech in their Hong Kong IPOs
Matters

Select Representations

  • Warburg Pincus, Sequoia Capital, Boyu Capital, New Horizon Capital, L Capital, Carlyle, and LightSpeed Venture in various private equity investment and exit transactions
  • Tencent, DJI International, and Shanda in various financing and investment transactions
  • The buyer consortium and management team in the going-private transaction of WuXi PharmaTech
  • RDA Microelectronics in its sale to Tsinghua Unigroup
  • Integrated Silicon Solution Inc. in its sale to a consortium of Chinese buyers
  • Founder of Syswin Inc. in its going-private transaction
  • TJOY Holdings in its sale to Coty Inc.
  • State Grid International Development in its acquisition of electric power transmission assets in Brazil
  • ArtGo Mining and PW Medtech in their Hong Kong IPOs
Focus Areas
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Emerging Companies and Venture Capital
  • Greater China
  • Mergers & Acquisitions
Recent Insights
Client Highlights
Wilson Sonsini Advises WuXi AppTec on Sale of China-Based Clinical Research Services Business to Hillhouse
On October 24, 2025, WuXi AppTec Co., Ltd. (WuXi AppTec), a leading global provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology, and medical device industries, announced that its wholly owned subsidiary has entered into a sale and purchase agreement to sell its two subsidiaries, WuXi Clinical Development Services (Shanghai) Co., Ltd. (WuXi Clinical) and WuXi MedKey Med-Tech Development (Shanghai) Co., Ltd. (WuXi MedKey), to Hillhouse Investment Management (Hillhouse), one of the world’s leading global private asset managers focusing on sectors such as healthcare, manufacturing, green energy, hard technology, and consumer technology. WuXi Clinical and WuXi MedKey are the operating entities of WuXi AppTec engaged in China-based clinical research services.

Wilson Sonsini Goodrich & Rosati advised WuXi AppTec on the transaction. The Wilson Sonsini team includes:
Learn More
Client Highlights
Wilson Sonsini Advises Warburg Pincus on Stake Increase in United Family Healthcare
On March 13, 2025, United Family Healthcare (UFH), a leading high-end private healthcare services company in China, announced that Warburg Pincus, a global private equity investment leader, would further increase its stake in UFH. Upon completion of the transaction, Warburg Pincus will become a significant shareholder of UFH and secure a seat on the board of directors, and Fosun Pharma will exit from UFH.
Learn More
View All
Recent Events
Affiliated Programs
China Healthcare Investment Conference (CHIC)
Wilson Sonsini is proud to sponsor the China Healthcare Investment Conference (CHIC).
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.